Ikarian Capital, LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$596,000
-17.5%
735,097
+5.9%
0.08%
-27.8%
Q4 2021$722,000
-12.6%
694,195
+48.9%
0.11%
+86.2%
Q3 2021$826,000466,2610.06%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GOFEN & GLOSSBERG LLC /IL/ 3,819,170$6,760,0000.16%
ARMISTICE CAPITAL, LLC 2,019,995$3,575,0000.06%
Ikarian Capital, LLC 466,261$826,0000.06%
Octagon Capital Advisors LP 30,600$54,0000.01%
FAS Wealth Partners, Inc. 58,326$103,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 46,531$82,0000.00%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
VANGUARD GROUP INC 363,069$642,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders